| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 832.7 | 736.0 | 910.6 |
| Other income | 28.0 | 25.3 | 15.4 |
| Total income | 860.7 | 761.3 | 926.0 |
| Profit before exceptional items & tax | 53.7 | -5.7 | 85.2 |
| Exceptional items | -6.7 | -13.5 | 0.0 |
| Profit before tax | 47.0 | -19.2 | 85.2 |
| Net profit | 32.2 | -9.0 | 67.1 |
| Operating margin | 5.5% | -2.5% | 9.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -52.00% |
|---|---|
| Revenue, year on year | -8.60% |
| Operating profit, year on year | -63.20% |
| Operating profit, quarter on quarter | +182.90% |
NSE results filing, NSE: SYNGENE. Figures extracted from the filing.
Syngene International Ltd: key numbers
- Share price
- ₹405.00
- Market cap
- ₹16,349 Cr
- Revenue (annual)
- ₹3,739 Cr
- Net profit (annual)
- ₹316.7 Cr
- P/E (TTM)
- 87.8×Sector 46.5×
- Promoter holding
- 52.59%+0.00% QoQ
- FII holding
- 10.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syngene International Ltd
All →Syngene International Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 833 Cr (down 9% YoY, up 13% QoQ). Operating EBITDA margin 18% on forex hedge losses. PAT before exceptionals Rs 38 Cr (down 44% YoY). Focus on integrated CRDMO and first Bayview biologics deal.
Syngene International Results Update
Syngene reported Q2 FY27 revenue of Rs 833 Crore, up 13% sequentially, with PAT of Rs 32 Crore. Release includes P&L highlights and business updates.
Syngene International Management Change
Syngene reports changes in senior management: two heads move from SMP to Non-SMP, Ajay Tandon resigns effective October 30, 2026, and CFO Deepak Jain plans to leave. The CFO is a KMP, so this is a material leadership change.
Syngene International Other Announcement
Syngene International Limited has submitted the quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.
Syngene International Board Meeting Date
Syngene International Limited will hold a board meeting on October 27, 2026, to approve the standalone and consolidated financial results for the quarter ended September 30, 2026.
Syngene International Management Change
Syngene International Limited announced the resignation of Mr. Pramuch Goel, Head of Corporate Affairs & Communications and Senior Management Personnel, effective September 21, 2026.